Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: Cancer. 2019 Apr 24;125(16):2732–2746. doi: 10.1002/cncr.32150

Figure 3.

Sequence of interventions associated with neoadjuvant rectal cancer clinical trial (NCT03300544) incorporating TVEC.

Figure 3.

#Patients with inadequate archival tissue for integrated biomarker analysis

^As part of pre-surgical evaluation or at a corresponding time point in patients not undergoing surgery

+Dose escalation will be done using a 3+3 design for a total of 15 patients that will be treated at MTD

TVEC = talimogene laherparepvec